Krystal Biotech Inc reports results for the quarter ended in January - Earnings Summary

Krystal Biotech

06/05/2024 14:32

* Krystal Biotech Inc  KRYS.OQ  reported quarterly adjusted
earnings of 3 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of $-1.76.  The mean expectation of
eight analysts for the quarter was for earnings of 15 cents per
share. Wall Street expected results to range from -10 cents
to 31 cents per share.
    * Revenue was $45.25 million​; analysts expected $47.42
million. 
    * Krystal Biotech Inc's reported EPS for the quarter was 3
cents​.
    * The company reported quarterly net income of $932
thousand.
    * Krystal Biotech Inc shares had fallen by 9.5% this
quarter and
gained 29.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 163.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Krystal Biotech
Inc is $197.50 
This summary was machine generated from LSEG data May 6 at 01:31
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.15           0.03           Missed
 Dec. 31 2023      -0.42          0.30           Beat
 Sep. 30 2023      -0.29          -0.69          Missed
 Jun. 30 2023      -0.74          -1.25          Missed